Galectin-9-CD44 Interaction Enhances Stability and Function of Adaptive Regulatory T Cells

被引:246
|
作者
Wu, Chuan [1 ]
Thalhamer, Theresa [1 ]
Franca, Rafael F. [1 ]
Xiao, Sheng [1 ]
Wang, Chao [1 ]
Hotta, Chie [1 ]
Zhu, Chen [1 ]
Hirashima, Mitsuomi [2 ]
Anderson, Ana C. [1 ]
Kuchroo, Vijay K. [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA
[2] Kagawa Univ, Fac Med, Dept Immunol & Immunopathol, Kagawa 7610793, Japan
基金
巴西圣保罗研究基金会; 奥地利科学基金会; 美国国家卫生研究院;
关键词
GROWTH-FACTOR-BETA; TGF-BETA; FOXP3; EXPRESSION; REG-CELLS; IN-VIVO; SIGNAL-TRANSDUCTION; DENDRITIC CELLS; RETINOIC-ACID; IFN-GAMMA; INFLAMMATION;
D O I
10.1016/j.immuni.2014.06.011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The beta-galactoside-binding protein galectin-9 is critical in regulating the immune response, but the mechanism by which it functions remains unclear. We have demonstrated that galectin-9 is highly expressed by induced regulatory T cells (iTreg) and was crucial for the generation and function of iTreg cells, but not natural regulatory T (nTreg) cells. Galectin-9 expression within iTreg cells was driven by the transcription factor Smad3, forming a feed-forward loop, which further promoted Foxp3 expression. Galectin-9 increased iTreg cell stability and function by directly binding to its receptor CD44, which formed a complex with transforming growth factor-beta (TGF-beta) receptor I (TGF-beta RI), and activated Smad3. Galectin-9 signaling was further found to regulate iTreg cell induction by dominantly acting through the CNS1 region of the Foxp3 locus. Our data suggest that exogenous galectin-9, in addition to being an effector molecule for Treg cells, acts synergistically with TGF-beta to enforce iTreg cell differentiation and maintenance.
引用
收藏
页码:270 / 282
页数:13
相关论文
共 50 条
  • [41] Combined CD44-and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models
    Maruoka, Yasuhiro
    Furusawa, Aki
    Okada, Ryuhei
    Inagaki, Fuyuki
    Fujimura, Daiki
    Wakiyama, Hiroaki
    Kato, Takuya
    Nagaya, Tadanobu
    Choyke, Peter L.
    Kobayashi, Hisataka
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 345 - 355
  • [42] Interaction between regulatory T cells and mast cells via IL-9 and TGF-β production
    Zhao, Yi-Bin
    Yang, Shao-Hui
    Shen, Jie
    Deng, Ke
    Li, Qi
    Wang, Yu
    Cui, Wei
    Ye, Hua
    ONCOLOGY LETTERS, 2020, 20 (06)
  • [43] CD4+CD25+Foxp3+ regulatory T cells prevent the development of Th1 immune response by inhibition of dendritic cell function during the early stage of Plasmodium yoelii infection in susceptible BALB/c mice
    Zheng, Wei
    Wang, Qing-hui
    Feng, Hui
    Liu, Jun
    Meng, Hong-rui
    Cao, Ya-ming
    FOLIA PARASITOLOGICA, 2009, 56 (04) : 242 - 250
  • [44] CD24 is expressed on FoxP3+ regulatory T cells and regulates their function
    Shi, Yun
    Zhu, Jing
    Liu, Jin-Qing
    Talebian, Fatemeh
    Li, Mingsong
    Bai, Xue-Feng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (04): : 2291 - 2300
  • [45] Gut Inflammation in Mice Triggers Proliferation and Function of Mucosal Foxp3+ Regulatory T Cells but Impairs Their Conversion from CD4+ T Cells
    Boschetti, Gilles
    Kanjarawi, Reem
    Bardel, Emilie
    Collardeau-Frachon, Sophie
    Duclaux-Loras, Remi
    Moro-Sibilot, Ludovic
    Almeras, Thibaut
    Flourie, Bernard
    Nancey, Stephane
    Kaiserlian, Dominique
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (01) : 105 - 117
  • [46] GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells
    Liao, Gongxian
    Nayak, Sushrusha
    Regueiro, Jose R.
    Berger, Scott B.
    Detre, Cynthia
    Romero, Xavier
    Malefyt, Rene de Waal
    Chatila, Talal A.
    Herzog, Roland W.
    Terhorst, Cox
    INTERNATIONAL IMMUNOLOGY, 2010, 22 (04) : 259 - 270
  • [47] Interleukin-10 Producing Regulatory B Cells Transformed CD4+CD25- Into Tregs and Enhanced Regulatory T Cells Function in Human Leprosy
    Tarique, Mohd
    Naz, Huma
    Kurra, Santosh V.
    Saini, Chaman
    Naqvi, Raza Ali
    Rai, Reeta
    Suhail, Mohd
    Khanna, Neena
    Rao, Donthamshetty N.
    Sharma, Alpana
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [48] Interleukin-37 Enhances the Suppressive Activity of Naturally Occurring CD4+ CD25+ Regulatory T Cells
    Wang, Da-Wei
    Dong, Ning
    Wu, Yao
    Zhu, Xiao-Mei
    Wang, Chun-Ting
    Yao, Yong-Ming
    SCIENTIFIC REPORTS, 2016, 6
  • [49] Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8+ T cells
    Rubinstein, Mark P.
    Su, Ee Wern
    Suriano, Samantha
    Cloud, Colleen A.
    Andrijauskaite, Kristina
    Kesarwani, Pravin
    Schwartz, Kristina M.
    Williams, Katelyn M.
    Johnson, C. Bryce
    Li, Mingli
    Scurti, Gina M.
    Salem, Mohamed L.
    Paulos, Chrystal M.
    Garrett-Mayer, Elizabeth
    Mehrotra, Shikhar
    Cole, David J.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (05) : 539 - 549
  • [50] CD177 modulates the function and homeostasis of tumor-infiltrating regulatory T cells
    Kim, Myung-Chul
    Borcherding, Nicholas
    Ahmed, Kawther K.
    Voigt, Andrew P.
    Vishwakarma, Ajaykumar
    Kolb, Ryan
    Kluz, Paige N.
    Pandey, Gaurav
    De, Umasankar
    Drashansky, Theodore
    Helm, Eric Y.
    Zhang, Xin
    Gibson-Corley, Katherine N.
    Klesney-Tait, Julia
    Zhu, Yuwen
    Lu, Jinglu
    Lu, Jinsong
    Huang, Xian
    Xiang, Hongrui
    Cheng, Jinke
    Wang, Dongyang
    Wang, Zheng
    Tang, Jian
    Hu, Jiajia
    Wang, Zhengting
    Liu, Hua
    Li, Mingjia
    Zhuang, Haoyang
    Avram, Dorina
    Zhou, Daohong
    Bacher, Rhonda
    Zheng, Song Guo
    Wu, Xuefeng
    Zakharia, Yousef
    Zhang, Weizhou
    NATURE COMMUNICATIONS, 2021, 12 (01)